Ventyx Biosciences Overview
Ventyx Biosciences Target Price
Analysts' 12-month price predictions for VTYX.
Get informed when a big investor buys or sells
+ FollowShare Price
$14
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-08 | Piper Sandler | $14 |  0% upside |  |
| 2026-01-08 | H.C. Wainwright | $14 | 0% upside | |
| 2026-01-08 | UBSMichael Yee | $14 | 0% upside | |
| 2026-01-08 | Canaccord GenuityEdward Nash | $14 | 0% upside | |
| 2026-01-07 | UBS | $20 | 42.9% upside | |
| 2025-11-05 | H.C. Wainwright | $18 | 28.6% upside | |
| 2025-10-27 | Oppenheimer | $14 | 0% upside | |
| 2024-06-13 | H.C. WainwrightEmily Bodnar | $6 |  57.1% downside | |
| 2024-06-06 | OppenheimerJeff Jones | $10 | 28.6% downside | |
| 2024-03-12 | Wells FargoDerek Archila | $16 | 14.3% upside | |
| 2024-03-12 | OppenheimerJeff Jones | $12 | 14.3% downside | |
| 2022-12-19 | Goldman Sachs | $50 | 257.1% upside | |
| 2022-11-17 | Morgan StanleyMatthew Harrison | $45 | 221.4% upside | |
| 2022-09-13 | JefferiesMichael Yee | $60 | 328.6% upside | |
| 2022-05-12 | Piper SandlerYasmeen Rahimi | $50 | 257.1% upside | |